Effectiveness of Substance Use Disorder Treatment As an Alternative to Imprisonment

Overview

Journal BMC Psychiatry

Publisher Biomed Central

Specialty Psychiatry

Date 2024 Apr 8

PMID 38589822

Authors

Suvi Virtanen

Mikko Aaltonen

Antti Latvala

Mats Forsman

Paul Lichtenstein

Zheng Chang

Affiliations

Soon will be listed here.

Abstract

Introduction: Drug courts are criminal justice programs to divert people with substance use disorders from incarceration into treatment. Drug courts have become increasingly popular in the US and other countries. However, their effectiveness in reducing important public health outcomes such as recidivism and substance-related health harms remains ambiguous and contested. We used nationwide register data from Sweden to evaluate the effectiveness of contract treatment sanction, the Swedish version of drug court, in reducing substance misuse, adverse somatic and mental health outcomes, and recidivism.

Methods: In this prospective cohort study, two quasi-experimental designs were used: difference-in-differences and the within-individual design. In the latter, we compared the risk of outcomes during time on contract treatment to, 1) parole after imprisonment and, 2) probation.

Results: The cohort included 11,893 individuals (13% women) who underwent contract treatment. Contract treatment was associated with a reduction of 7 percentage points (95% CI: -.088, -.055) in substance misuse, 5 percentage points (-.064, -.034) in adverse mental health events, 9 percentage points (-.113, -.076) in adverse somatic health events, and 3 fewer charges (-3.16, -2.85) for crime in difference-in-differences analyses. Within-individual associations suggested that the same individual had longer times-to-event for all outcomes during contract treatment than on parole or on probation.

Conclusions: Contract treatment is an effective intervention from both public health and criminal justice perspective. Our findings suggest that it is a superior alternative to incarceration in its target group. Further, we find that an implementation approach that is less punitive and more inclusive than what is typical in the US can be successful.

References

Taxman F, Thanner M, Weisburd D . Risk, Need, And Responsivity (RNR): It All Depends. Crime Delinq. 2008; 52(1):28-51. PMC: 2423325. DOI: 10.1177/0011128705281754. View

DeMatteo D, Marlowe D, Festinger D, Arabia P . Outcome Trajectories in Drug Court: Do All Participants Have Drug Problems?. Crim Justice Behav. 2011; 36(4):354-368. PMC: 3211110. DOI: 10.1177/0093854809331547. View

Matusow H, Dickman S, Rich J, Fong C, Dumont D, Hardin C . Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes. J Subst Abuse Treat. 2012; 44(5):473-80. PMC: 3602216. DOI: 10.1016/j.jsat.2012.10.004. View

Csete J . Criminal Justice Barriers to Treatment of Opioid Use Disorders in the United States: The Need for Public Health Advocacy. Am J Public Health. 2019; 109(3):419-422. PMC: 6366485. DOI: 10.2105/AJPH.2018.304852. View

Gottfredson D, Kearley B, Najaka S, Rocha C . The Baltimore City Drug Treatment Court: 3-year self-report outcome study. Eval Rev. 2004; 29(1):42-64. DOI: 10.1177/0193841X04269908. View

Marinelli-Casey P, Gonzales R, Hillhouse M, Ang A, Zweben J, Cohen J . Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes. J Subst Abuse Treat. 2007; 34(2):242-8. DOI: 10.1016/j.jsat.2007.04.005. View

Joudrey P, Howell B, Nyhan K, Moravej A, Doernberg M, Ross J . Reporting of substance use treatment quality in United States adult drug courts. Int J Drug Policy. 2020; 90:103050. PMC: 8046712. DOI: 10.1016/j.drugpo.2020.103050. View

Belenko S . The challenges of conducting research in drug treatment court settings. Subst Use Misuse. 2002; 37(12-13):1635-64. DOI: 10.1081/ja-120014425. View

Wittouck C, Dekkers A, De Ruyver B, Vanderplasschen W, Vander Laenen F . The impact of drug treatment courts on recovery: a systematic review. ScientificWorldJournal. 2013; 2013:493679. PMC: 3618932. DOI: 10.1155/2013/493679. View

10.

Frank R, Pollack H . Addressing the Fentanyl Threat to Public Health. N Engl J Med. 2017; 376(7):605-607. DOI: 10.1056/NEJMp1615145. View

11.

Marlowe D . Integrating substance abuse treatment and criminal justice supervision. Sci Pract Perspect. 2008; 2(1):4-14. PMC: 2851043. DOI: 10.1151/spp03214. View

12.

Charlet K, Heinz A . Harm reduction-a systematic review on effects of alcohol reduction on physical and mental symptoms. Addict Biol. 2016; 22(5):1119-1159. DOI: 10.1111/adb.12414. View

13.

Brown R . Systematic review of the impact of adult drug-treatment courts. Transl Res. 2010; 155(6):263-74. PMC: 2886018. DOI: 10.1016/j.trsl.2010.03.001. View